Mrs. Carmen Iris Laboy, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 99 Guillermo Riefkohl St., Patillas, PR 00723 Phone: 787-839-4320 Fax: 787-271-0004 |
Mrs. Migdalia Soto, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 99 Guillermo Riefkohl St., Patillas, PR 00723 Phone: 787-839-4320 Fax: 787-271-0004 |
Mrs. Gloria De Alba, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 99 Guillermo Riefkohl St., Patillas, PR 00723 Phone: 787-839-4320 Fax: 787-271-0004 |
Mrs. Nelida Flores, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 99 Guillermo Riefkohl St., Patillas, PR 00723 Phone: 787-839-4320 Fax: 787-271-0004 |
Virginia Montanez, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 99 Guillermo Riefkhol Street, Patillas, PR 00723 Phone: 787-839-4320 Fax: 787-271-0004 |
Mrs. Wanda Alicea, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 99 Guillermo Riefkohl St., Patillas, PR 00723 Phone: 787-839-4320 Fax: 787-271-0004 |
News Archive
The novel coronavirus is continuing to spread worldwide, with more than 113,000 cases and now more than 4,000 deaths. In the United States, health officials urge residents not to panic due to the viral infection's low mortality rate. Still, they advise that older people are at the highest risk of coronavirus disease (COVID-19).
At the 99th Scientific Assembly and Annual Meeting of the Radiological Society of North America, December 1-6 in Chicago, Siemens Healthcare (booth #1934, South Building/Lakeside Center at McCormick Place, Hall A) will introduce a new angiography system optimized for broad clinical utilization.
Rules-Based Medicine, Inc. (RBM) today announced that Psynova Neurotech Limited (Cambridge UK), a majority-owned subsidiary of RBM, has executed an exclusive research and licensing agreement with Roche to collaborate on the discovery, development, validation and commercialization of diagnostic immunoassays to aid the clinical development and commercial differentiation of novel treatments for schizophrenia.
InterMune, Inc. today announced that it has submitted an electronic New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis (IPF). Pirfenidone has been granted Orphan Drug and Fast Track designation by the FDA, and also has been granted Orphan Drug status in Europe.
In the largest German survey on heart failure to date, investigators found that the overall awareness of heart failure has not increased over the past decade and is not at a satisfactory level.
› Verified 7 days ago